Stitch showdown: can a simple change prevent hernias after liver surgery?
NCT ID NCT04982653
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether a different way of closing the abdominal wall during liver tumor surgery can lower the chance of developing an incisional hernia. 140 patients will be randomly assigned to receive either the new 'short stitch' method or the traditional closure. Researchers will track hernia rates using scans at 3, 6, and 12 months after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- surgical closure technique (short stitch suture vs. traditional suture)
- What this could lead to
- If successful, this could establish a simple change in surgical stitching that reduces the risk of incisional hernias after liver surgery.
- What could go wrong
- This is a Phase 2 trial with 140 patients, so results may not apply to all surgeries. The benefit may be small or not statistically significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER AND INTRAHEPATIC BILE DUCT NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Double immunotherapy plus liver blockade targets eye cancer that spreads
- Could a pill help the liver regrow and make more cancer surgeries possible?
- Liver-Directed chemo shows promise for eye cancer metastases
- New drug AU409 enters first human trial for tough liver cancers
- New scan could reveal how liver tumors respond to chemo
- Liver surgery combo fails to show clear survival edge in advanced colorectal cancer